|
Nov 16, 2018
The post Generating Cash Flow Through High-Quality Fixed Income appeared first on The Wall Street Transcript.
|
|
Nov 16, 2018
The post Using a Thematic, Bottom-Up Approach to Invest in Global Financial Services appeared first on The Wall Street Transcript.
|
|
Nov 16, 2018
The post Positively Impacting Society Through Investments in West Africa appeared first on The Wall Street Transcript.
|
|
Nov 16, 2018
John A. Heffern is the Founder/Principal of KCA/Princeton Advisors. He applies 30 years of portfolio management and research experience, particularly in the areas of domestic small-cap/midcap equities and the financial services sector. He holds both a bachelor's degree and MBA from the University of North Carolina.
The post Heffern, John A. appeared first on The Wall Street Transcript.
|
|
Nov 16, 2018
Kimberly C. Friedricks is Managing Director of Fixed Income at Kayne Anderson Rudnick. Before joining Kayne Anderson Rudnick in 1998, Ms. Friedricks was responsible for management of fixed income trading, fundamental research and portfolio management, specializing in municipal-credit analysis for a specialty-management firm in Beverly Hills, California. Ms. Friedricks attended the University of Southern California […]
The post Friedricks, Kimberly C. appeared first on The Wall Street Transcript.
|
|
Nov 16, 2018
Danladi Verheijen is the Managing Partner and Co-Founder of Verod Capital Management. Prior to founding Verod, Mr. Verheijen held roles at Citibank Nigeria, Ocean and Oil Holdings and at McKinsey & Company. He received an MBA from Harvard Business School, an M.S. in engineering economic systems and operations research from Stanford University and a B.S. […]
The post Verheijen, Danladi appeared first on The Wall Street Transcript.
|
|
Nov 16, 2018
The post Focusing on Health Care Through Venture Capital and a Crossover Fund appeared first on The Wall Street Transcript.
|
|
Nov 16, 2018
The post Looking for Small-Cap Value Stocks with Competent Management Teams appeared first on The Wall Street Transcript.
|
|
Nov 16, 2018
Bill Caton, CFA, is a Research Analyst and Senior Trader at First Wilshire Securities Management Inc. With responsibilities in portfolio management and trading, Mr. Caton joined First Wilshire's internship program over 20 years ago and advanced through the ranks. Today, he is a member of the investment committee. He holds a bachelor's degree from the […]
The post Caton, Bill appeared first on The Wall Street Transcript.
|
|
Nov 16, 2018
Dr. Ansbert Gadicke is Co-Founder and Managing Director of MPM Capital, Inc., and its venture capital activities as well as its oncology-only crossover investment strategy — both public and private equities. He and his partner, Luke Evnin, Ph.D., founded MPM in 1997, and since then, the MPM team they have led has been the inspiration […]
The post Gadicke, Dr. Ansbert appeared first on The Wall Street Transcript.
|
|
Nov 16, 2018
The post Finding Bottom-Up Opportunities in Health Care appeared first on The Wall Street Transcript.
|
|
Nov 16, 2018
Mark E. Eveans, CFA, CIC, is President, Chief Investment Officer and Senior Portfolio Manager at Meritage Portfolio Management. Mr. Eveans is a founding Principal of Meritage. He serves as the lead manager of the Meritage Value Equity strategy, supports the Yield-Focus and Small Cap Value Equity strategies, and drives the firm's overall investment philosophy. Mr. Eveans […]
The post Eveans, Mark E. appeared first on The Wall Street Transcript.
|
|
Nov 16, 2018
The post Going Against the Trend with a Buy-and-Hold Strategy appeared first on The Wall Street Transcript.
|
|
Nov 16, 2018
The post Identifying Reliable and Predictable Sources of Return appeared first on The Wall Street Transcript.
|
|
Nov 16, 2018
Benjamin Miller is Managing Director at Underhill Investment Management, LLC. He joined Underhill Investment Management as an investment professional in the fall of 2013 with over 20 years' experience in the investment industry. Prior to joiningUnderhill Investment Management, Mr. Miller was a portfolio manager with Seasons Capital and Millennium Management. He entered the securities industry […]
The post Miller, Benjamin appeared first on The Wall Street Transcript.
|
|
Nov 16, 2018
Roland Underhill is Principal Managing Director at Underhill Investment Management, LLC. He joined Underhill Investment Management, LLC in 2009 after more than 45 years in the investment business in Los Angeles, New York and Marin County, California. He was a general partner with Lateef Investment Associates from 1994 to 2007, during which time firm assets […]
The post Underhill, Roland appeared first on The Wall Street Transcript.
|
|
Nov 16, 2018
The post Seeking Undervalued Small Caps with Leveraged Balance Sheets appeared first on The Wall Street Transcript.
|
|
Nov 16, 2018
The post Obtaining Sensible Returns with a Disciplined Methodology appeared first on The Wall Street Transcript.
|
|
Nov 15, 2018
Peter Jones, CFA, joined Ferguson Wellman Capital Management in 2015 and is Vice President of Research. Mr. Jones leads the firm's Global Sustainable Investing strategy team, is an analyst and a member of the firm's investment team. He develops and manages the multifactor model […]
The post Global Sustainable Investing (GSI) is the Strategy for this Portland Based Asset Manager appeared first on The Wall Street Transcript.
|
|
Nov 15, 2018
Peter Strzalkowski, CFA, serves as Co-Team Leader of OppenheimerFunds' Investment Grade Debt team and is a Portfolio Manager of the Total Return Bond Fund, Oppenheimer Limited-Term Government Fund and Oppenheimer Limited-Term Bond Fund. Before joining the firm in August 2007, Mr. Strzalkowski served as Managing Partner and Chief Investment Officer of Vector Capital Management, LLC, […]
The post Investment Grade Debt Generates Alpha for thisTop Level Portfolio Manager appeared first on The Wall Street Transcript.
|
|
Nov 15, 2018
Thomas W. McDowell is Chief Executive Officer and Chief Investment Officer at Rice Hall James & Associates, LLC. He has been with the firm for 34 years and has 38 years of industry experience. He works on the SMID Cap Equity, Small Cap Equity and Micro Cap Equity strategies. He started at the firm as a […]
The post Growth at a Reasonable Price Investing Lives On with Cara Thome and Thomas McDowell appeared first on The Wall Street Transcript.
|
|
Nov 13, 2018
Clay Kirkland, CFA, is a Vice President and Portfolio Manager at Intrepid Capital. He is the Lead Portfolio Manager of the Intrepid Disciplined Value Fund and the separately managed Intrepid Disciplined Value portfolio. He is also the Co-Lead Portfolio Manager of the Intrepid Select Fund and the separately managed Intrepid Select portfolio. Mr. Kirkland focuses […]
The post Clay Kirkland Reveals His Top Picks as Portfolio Manager at Intrepid Capital appeared first on The Wall Street Transcript.
|
|
Nov 13, 2018
Brian Washkowiak, CFA, is a Portfolio Manager at Fairpointe Capital, LLC. Mr. Washkowiak is part of the Mid-Cap Investment Team, serving as Co-Portfolio Manager for the midcap strategy, including the AMG Managers Fairpointe Mid Cap Fund, Parvest Equity USA Mid Cap Fund, and institutional and private client accounts. His responsibilities include investment research and portfolio […]
The post Majority Female-Owned Asset Management Firm Fairpointe Capital Reveals Mid Cap Top Picks appeared first on The Wall Street Transcript.
|
|
Nov 13, 2018
Jason Benowitz, CFA, is Senior Portfolio Manager at Roosevelt Investments. He first went to work at the firm in 2009 as a securities analyst, was promoted to Portfolio Manager in 2011 and to Senior Portfolio Manager in 2013. Prior to Roosevelt, Mr. Benowitz was a principal at Druker Capital, a long/short hedge fund manager, and […]
The post Botox Maker Allergan is a Top Pick from Award Winning Portfolio Manager for Roosevelt Investments appeared first on The Wall Street Transcript.
|
|
Nov 13, 2018
Donald Easley, CFA, is a Portfolio Manager in the U.S. Equity Division of T. Rowe Price for the U.S. Tax-Efficient and U.S. Structured Active Mid-Cap Growth Equity Strategies. He works closely with Don Peters, a portfolio manager in the U.S. Equity Division, actively assisting with all aspects of portfolio management. Mr. Easley is an Executive […]
The post Donald Easley Puts his Award-Winning Portfolio Management Expertise on Display appeared first on The Wall Street Transcript.
|
|
Nov 13, 2018
James Morton is Chief Investment Officer and a Portfolio Manager at Santa Lucia Asset Management Ltd. He has extensive expertise in recovering and small-cap companies, as well as emerging markets. Mr. Morton's career in the investment industry began in 1985, and he has been a consultant to Mackenzie Cundill since 1996. He is an accomplished author, […]
The post China Yongda (HKG:3669) is Only One of Many Contrarian China Equity Plays from James Morton of Santa Lucia Asset Management appeared first on The Wall Street Transcript.
|
|
Nov 02, 2018
The post Applying Thematic Insights Across Sectors in an All-Cap Strategy appeared first on The Wall Street Transcript.
|
|
Nov 02, 2018
The post Buying Domestic Companies in China at Cheap Valuations appeared first on The Wall Street Transcript.
|
|
Nov 02, 2018
The post Building a Global Strategy From the Bottom Up appeared first on The Wall Street Transcript.
|
|
Nov 02, 2018
The post Looking for Inefficiently Priced Stocks in the Midcap Space appeared first on The Wall Street Transcript.
|
|
Nov 02, 2018
The post Capturing the Spirit of the Midcap Growth Space appeared first on The Wall Street Transcript.
|
|
Nov 02, 2018
Grady Burkett, CFA, is a Portfolio Manager and Research Analyst at Diamond Hill Capital Management, Inc. He joined the firm in 2014. Earlier, he worked in the technology and telecommunication sectors — as well as institutional equity research sales at Morningstar. He received both an M.S. and B.S. in mathematics from Wright State University.
The post Burkett, Grady appeared first on The Wall Street Transcript.
|
|
Nov 02, 2018
Brian Washkowiak, CFA, is a Portfolio Manager at Fairpointe Capital, LLC. Mr. Washkowiak is part of the Mid-Cap Investment Team, serving as Co-Portfolio Manager for the midcap strategy, including the AMG Managers Fairpointe Mid Cap Fund, Parvest Equity USA Mid Cap Fund, and institutional and private client accounts. His responsibilities include investment research and portfolio […]
The post Washkowiak, Brian appeared first on The Wall Street Transcript.
|
|
Nov 02, 2018
The post Looking for the Best Dividend Yields by Industry appeared first on The Wall Street Transcript.
|
|
Nov 02, 2018
The post Buying Growing Small-Cap Companies at Attractive Valuations appeared first on The Wall Street Transcript.
|
|
Nov 02, 2018
The post Aiming for Good Risk-Adjusted Returns Over a Full Market Cycle appeared first on The Wall Street Transcript.
|
|
Nov 02, 2018
Clay Kirkland, CFA, is a Vice President and Portfolio Manager at Intrepid Capital. He is the Lead Portfolio Manager of the Intrepid Disciplined Value Fund and the separately managed Intrepid Disciplined Value portfolio. He is also the Co-Lead Portfolio Manager of the Intrepid Select Fund and the separately managed Intrepid Select portfolio. Mr. Kirkland focuses […]
The post Kirkland, Clay appeared first on The Wall Street Transcript.
|
|
Nov 02, 2018
Cara M. Thome is a Portfolio Manager and Analyst at Rice Hall James & Associates, LLC. She has been at the firm for 17 years and has 21 years of industry experience. She works on the SMID Cap Equity, Small Cap Equity and Micro Cap Equity strategies. Before joining the firm, she worked as an […]
The post Thome, Cara M. appeared first on The Wall Street Transcript.
|
|
Nov 02, 2018
Thomas W. McDowell is Chief Executive Officer and Chief Investment Officer at Rice Hall James & Associates, LLC. He has been with the firm for 34 years and has 38 years of industry experience. He works on the SMID Cap Equity, Small Cap Equity and Micro Cap Equity strategies. He started at the firm as […]
The post McDowell, Thomas W. appeared first on The Wall Street Transcript.
|
|
Nov 02, 2018
R. Burns McKinney, CFA, is a Lead Portfolio Manager, an Analyst, a Managing Director and a CIO Value Equity US with Allianz Global Investors. He is the product team co-lead for the Dividend Value investment strategy. Mr. McKinney has 21 years of investment-industry experience. Before joining the firm in 2006, he was an equity analyst […]
The post McKinney, R. Burns appeared first on The Wall Street Transcript.
|
|
Nov 02, 2018
The post Seeking a Total Return Greater Than the Rate of Inflation appeared first on The Wall Street Transcript.
|
|
Nov 02, 2018
The post Allocating Based on Risk in Domestic Investment-Grade Bond Funds appeared first on The Wall Street Transcript.
|
|
Nov 02, 2018
The post Managing an ESG Strategy with the Same Risk/Reward as a Traditional Portfolio appeared first on The Wall Street Transcript.
|
|
Nov 02, 2018
Tara Kinateder is an Executive Vice President, a member of Ferguson Wellman Capital Management's wealth management team and a member of the firm's Global Sustainable Investing strategy team. Ms. Kinateder is a portfolio manager with clients concentrated in Oregon, Washington and California. She specializes in wealth management planning and preservation through asset allocation and cash […]
The post Kinateder, Tara appeared first on The Wall Street Transcript.
|
|
Nov 02, 2018
Peter Jones, CFA, joined Ferguson Wellman Capital Management in 2015 and is Vice President of Research. Mr. Jones leads the firm's Global Sustainable Investing strategy team, is an analyst and a member of the firm's investment team. He develops and manages the multifactor model used by the investment team for its equity selection process. Mr. […]
The post Jones, Peter appeared first on The Wall Street Transcript.
|
|
Nov 02, 2018
Peter Strzalkowski, CFA, serves as Co-Team Leader of OppenheimerFunds' Investment Grade Debt team and is a Portfolio Manager of the Core Plus Bond strategy, Oppenheimer Limited-Term Government Fund and Oppenheimer Limited-Term Bond Fund. Before joining the firm in August 2007, Mr. Strzalkowski served as Managing Partner and Chief Investment Officer of Vector Capital Management, LLC, […]
The post Strzalkowski, Peter appeared first on The Wall Street Transcript.
|
|
Nov 02, 2018
Harris L. Kempner Jr., known as "Shrub," is President and Portfolio Manager at Kempner Capital Management, Inc. Harris Kempner has been KCM's President since the firm's inception in 1982. He was President of U.S. National Bancshares and Chief Investment Officer for Frost Bank of Galveston — formerly United States National Bank — from 1969 to […]
The post Kempner Jr., Harris L. appeared first on The Wall Street Transcript.
|
|
Nov 01, 2018
Geoff MacKay is President and Chief Executive Officer of AVROBIO, Inc. Mr. MacKay is an experienced CEO with proven success leading innovative businesses. While CEO of Organogenesis Inc., the company treated 1 million patients with living cell therapies, received the first FDA CBER allogeneic cell-therapy approval and achieved an unparalleled position within regenerative medicine. Mr. MacKay […]
The post Fabry Disease, Gaucher Disease, Pompe Disease and Cystinosis: AVROBIO has One Gene Therapy Platform to Treat them All appeared first on The Wall Street Transcript.
|
|
Oct 31, 2018
Gil Beyen is Chief Executive Officer and Chairman of ERYTECH Pharma. For ERYTECH, Gil Beyen has served as the Chief Executive Officer since May 2013 and Chairman of the board since 2012. Prior to his appointment as Chief Executive Officer, he assisted the company in a consulting role as of 2012 and also served as Chairman […]
The post Gil Beyen, CEO and Chairman of ERYTECH Pharma, Explains the Phase III Cancer Cure from his Company appeared first on The Wall Street Transcript.
|
|
Oct 25, 2018
Keith J. Kendall is Chief Executive Officer of Aquestive Therapeutics. Keith Kendall assumed the role of Chief Executive Officer at Aquestive in 2014 after serving as Co-President and Chief Operating Officer for the company since 2011. Mr. Kendall also served as Executive Vice President and Chief Financial Officer of Aquestive since July 2006. From February 1999 […]
The post Keith Kendall, CEO of Aquestive, Reveals the Muliple Product Launch Strategy that will Drive the Stock Price for His Investors appeared first on The Wall Street Transcript.
|
|
Oct 25, 2018
Anil R. Diwan, Ph.D., has been President and Chairman of the board of NanoViricides, Inc., since its founding in 2005. Dr. Diwan spearheaded the efforts for the company's 2013 uplisting from the OTC Markets to […]
The post Polymeric Micelle-based Nanomedicine Innovator Ready to Take Off for Investors appeared first on The Wall Street Transcript.
|
|
Oct 25, 2018
Lawrence J. Pavelec, CFA, is Chief Operating Officer, Executive Vice President and Portfolio Manager at Nicholas Company, Inc. He has 34 years of industry experience and has been […]
The post Snap-on Tools is the Type of Enduring Brand Based Business that Fuel's this Award Winning Portfolio Management Firm appeared first on The Wall Street Transcript.
|
|
Oct 25, 2018
Lawrence J. Pavelec, CFA, is Chief Operating Officer, Executive Vice President and Portfolio Manager at Nicholas Company, Inc. He has 34 years of industry experience and has been […]
The post Snap-on Tools is the Type of Enduring Brand Based Business that Fuels this Award Winning Portfolio Management Firm appeared first on The Wall Street Transcript.
|
|
Oct 23, 2018
Marc Voigt is Executive Director and Chief Executive Officer of Immutep Limited. Mr. Voigt has served as the Chief Financial Officer and Chief Business Officer since 2012 and was appointed as CEO and Executive Director in July 2014. He has extensive experience in the corporate and biotechnology sectors. He has previously worked as a personal assistant […]
The post Immuno-Oncology Divisions of Novartis and GlaxoSmithKline are Licensing from this Microcap Biotech appeared first on The Wall Street Transcript.
|
|
Oct 23, 2018
The post Interview with the CEO: Entera Bio Ltd. (NASDAQ:ENTX) appeared first on The Wall Street Transcript.
|
|
Oct 23, 2018
The post Interview with the CEO and the President and Chairman: NanoViricides, Inc. (NYSEAMERICAN:NNVC) appeared first on The Wall Street Transcript.
|
|
Oct 23, 2018
Phillip Schwartz, Ph.D., is Chief Executive Officer of Entera Bio Ltd. Dr. Schwartz has more than 20 years of biotech and pharmaceutical industry experience. He has served as CEO and director of the board of directors of Entera since its inception in 2010. Previously, he held multiple positions in medical affairs, business development and clinical […]
The post Schwartz, Phillip appeared first on The Wall Street Transcript.
|
|
Oct 23, 2018
Anil R. Diwan, Ph.D., has been President and Chairman of the board of NanoViricides, Inc., since its founding in 2005. Dr. Diwan spearheaded the efforts for the company's 2013 uplisting from the OTC Markets to NYSE American. Dr. Diwan has led several of the company's financing efforts since 2010. Dr. Diwan invented novel polymeric micelle-based […]
The post Diwan, Anil R. appeared first on The Wall Street Transcript.
|
|
Oct 23, 2018
Irach B. Taraporewala is Chief Executive Officer of NanoViricides, Inc. Dr. Irach B. Taraporewala is a seasoned pharmaceutical executive with over 25 years' experience in drug development and regulatory strategy. He is a hands-on CEO with strong scientific background combined with significant management, leadership, business development and financing experience. Dr. Taraporewala is the Founder and […]
The post Taraporewala, Irach B. appeared first on The Wall Street Transcript.
|
|
Oct 23, 2018
Nader Z. Pourhassan, Ph.D., is President and Chief Executive Officer of CytoDyn Inc. Dr. Pourhassan was appointed a director in September 2012 and has served as CytoDyn's President and Chief Executive Officer since September 2012. He was the company's Managing Director of Business Development from June 2011 to December 2012 and Chief Operating Officer from […]
The post CytoDyn About to Take Off? CEO Nader Pourhassan Ph. D. Says Yes appeared first on The Wall Street Transcript.
|
|
Oct 23, 2018
Bernard Gilly, Ph.D., a Co-Founder of GenSight Biologics, has served as its Chief Executive Officer since its founding. From creation through to 2016, Dr. Gilly served as Chairman of the board of directors. From 2011 through 2014, he served as Chief Executive Officer at Pixium Vision, and from which date, he has served as nonexecutive […]
The post Bernard Gilly, Ph.D, Co-Founder of GenSight Biologics Discusses the Proprietary Genetic Therapy Cure for Blindness his Company is Developing appeared first on The Wall Street Transcript.
|
|
Oct 22, 2018
John P. Calamos Sr. is Chairman and Global CIO of Calamos Investments, a firm he founded in 1977. With origins as an institutional convertible bond manager, the firm has grown into a global asset management firm. Mr. Calamos has established research and investment processes centered around a team-based approach designed to deliver superior risk-adjusted performance over […]
The post Calamos Investments Chairman Details His Convertible Bond Investment Portfolio Development appeared first on The Wall Street Transcript.
|
|
Oct 22, 2018
Frederick L. Weiss, CFA, is a Senior Investment Manager and leads the research efforts of CIBC Private Wealth Management's investment team. Mr. Weiss is also co-manager of the firm's Mid-Cap Growth Equity Strategy, where he is responsible for researching the technology and health care sectors of the market. He came to the firm in 1989 […]
The post Percutaneous Valve Replacement Therapy Just One Healthcare Investing Theme for Equity Strategy appeared first on The Wall Street Transcript.
|
|
Oct 22, 2018
John J. Flynn is Principal and Portfolio Manager at Pzena Investment Management. Mr. Flynn is a co-portfolio manager for the U.S. small-, mid- and large-cap value strategies. Mr. Flynn also serves as a co-portfolio manager for the Pzena Mid Cap Value Fund and the Pzena Small Cap Value Fund. In this capacity, he is part of […]
The post Pzena Investment Management Portfolio Manager John J. Flynn Captures the Upside appeared first on The Wall Street Transcript.
|
|
Oct 19, 2018
The post Investing Strategies appeared first on The Wall Street Transcript.
|
|
Oct 19, 2018
The post Taking the Emotion Out of the Investing Process appeared first on The Wall Street Transcript.
|
|
Oct 19, 2018
The post Selecting Securities to Own for the Long Term appeared first on The Wall Street Transcript.
|
|
Oct 19, 2018
Michael L. Shelton, CFA, CPA, is Senior Research Analyst and Portfolio Manager at Nicholas Company, Inc. He has 22 years of industry experience. He has been at Nicholas Company for 12 years. He is Lead Portfolio Manager at the Nicholas Equity Income Fund, Inc., and Co-Portfolio Manager at the Nicholas Fund, Inc. Mr. Shelton has […]
The post Shelton, Michael L. appeared first on The Wall Street Transcript.
|
|
Oct 19, 2018
Lawrence J. Pavelec, CFA, is Chief Operating Officer, Executive Vice President and Portfolio Manager at Nicholas Company, Inc. He has 34 years of industry experience and has been at Nicholas Company for 15 years, where he is a portfolio manager for the Nicholas High Income Fund, Inc. He collaborates with the other senior members of […]
The post Pavelec, Lawrence J. appeared first on The Wall Street Transcript.
|
|
Oct 19, 2018
The post Specializing in the Marijuana Industry and the Tech Sector appeared first on The Wall Street Transcript.
|
|
Oct 19, 2018
The post Buying High-Quality Midcaps with Opportunity to Grow Over the Long Term appeared first on The Wall Street Transcript.
|
|
Oct 19, 2018
John J. Flynn is Principal and Portfolio Manager at Pzena Investment Management. Mr. Flynn is a co-portfolio manager for the U.S. small-, mid- and large-cap value strategies. Mr. Flynn also serves as a co-portfolio manager for the Pzena Mid Cap Value Fund and the Pzena Small Cap Value Fund. In this capacity, he is part […]
The post Flynn, John J. appeared first on The Wall Street Transcript.
|
|
Oct 19, 2018
The post Using Convertibles for the Equity Upside and Downside Protection appeared first on The Wall Street Transcript.
|
|
Oct 19, 2018
Frederick L. Weiss, CFA, is a Senior Investment Manager and leads the research efforts of CIBC Private Wealth Management's investment team. Mr. Weiss is also co-manager of the firm's Mid-Cap Growth Equity Strategy, where he is responsible for researching the technology and health care sectors of the market. He came to the firm in 1989 […]
The post Weiss, Frederick L. appeared first on The Wall Street Transcript.
|
|
Oct 19, 2018
David C. Hartzell Jr. is President and CEO of Cornell Capital Management. He currently serves on The Business Week Alliance/Market Advisory Board and the Barron's "BIG MONEY" panel of experts. He is an ex-officio member of the board of directors of the FBI Citizens Academy Foundation; the board of directors of the Chantal Avin Rosin […]
The post Hartzell Jr., David C. appeared first on The Wall Street Transcript.
|
|
Oct 19, 2018
John P. Calamos Sr. is Chairman and Global CIO of Calamos Investments, a firm he founded in 1977. With origins as an institutional convertible bond manager, the firm has grown into a global asset management firm. Mr. Calamos has established research and investment processes centered around a team-based approach designed to deliver superior risk-adjusted performance […]
The post Calamos Sr., John P. appeared first on The Wall Street Transcript.
|
|
Oct 19, 2018
The post Interview with the CEO: Aquestive Therapeutics (NASDAQ:AQST) appeared first on The Wall Street Transcript.
|
|
Oct 19, 2018
The post Interview with the CEO, CFO and COO: Navidea Biopharmaceuticals, Inc. (NYSEAMERICAN:NAVB) appeared first on The Wall Street Transcript.
|
|
Oct 19, 2018
The post Interview with the CEO and Chairman: ERYTECH Pharma (NASDAQ:ERYP) appeared first on The Wall Street Transcript.
|
|
Oct 19, 2018
Keith J. Kendall is Chief Executive Officer of Aquestive Therapeutics. Keith Kendall assumed the role of Chief Executive Officer at Aquestive in 2014 after serving as Co-President and Chief Operating Officer for the company since 2011. Mr. Kendall also served as Executive Vice President and Chief Financial Officer of Aquestive since July 2006. From February […]
The post Kendall, Keith J. appeared first on The Wall Street Transcript.
|
|
Oct 19, 2018
Jed A. Latkin is interim Chief Executive Officer, Chief Financial Officer and Chief Operating Officer of Navidea Biopharmaceuticals, Inc. Mr. Latkin was appointed interim CEO in August 2018 after first becoming the company's Chief Operating Officer in April 2016 and, at that time, also replacing the Chief Financial Officer in an interim capacity. He has […]
The post Latkin, Jed A. appeared first on The Wall Street Transcript.
|
|
Oct 19, 2018
The post Interview with the Executive Director and CEO: Immutep Limited (NASDAQ:IMMP) appeared first on The Wall Street Transcript.
|
|
Oct 19, 2018
The post Interview with the President and CEO: CytoDyn Inc. (OTCMKTS:CYDY) appeared first on The Wall Street Transcript.
|
|
Oct 19, 2018
Gil Beyen is Chief Executive Officer and Chairman of ERYTECH Pharma. For ERYTECH, Gil Beyen has served as the Chief Executive Officer since May 2013 and Chairman of the board since 2012. Prior to his appointment as Chief Executive Officer, he assisted the company in a consulting role as of 2012 and also served as […]
The post Beyen, Gil appeared first on The Wall Street Transcript.
|
|
Oct 19, 2018
Marc Voigt is Executive Director and Chief Executive Officer of Immutep Limited. Mr. Voigt has served as the Chief Financial Officer and Chief Business Officer since 2012 and was appointed as CEO and Executive Director in July 2014. He has extensive experience in the corporate and biotechnology sectors. He has previously worked as a personal […]
The post Voigt, Marc appeared first on The Wall Street Transcript.
|
|
Oct 19, 2018
Nader Z. Pourhassan, Ph.D., is President and Chief Executive Officer of CytoDyn Inc. Dr. Pourhassan was appointed a director in September 2012 and has served as CytoDyn's President and Chief Executive Officer since September 2012. He was the company's Managing Director of Business Development from June 2011 to December 2012 and Chief Operating Officer from […]
The post Pourhassan, Nader Z. appeared first on The Wall Street Transcript.
|
|
Oct 19, 2018
The post Interview with the President, CEO and Director: Mustang Bio, Inc. (NASDAQ:MBIO) appeared first on The Wall Street Transcript.
|
|
Oct 19, 2018
The post Interview with the President and CEO: AVROBIO, Inc. (NASDAQ:AVRO) appeared first on The Wall Street Transcript.
|
|
Oct 19, 2018
The post Interview with the Co-Founder and CEO: GenSight Biologics (EPA:SIGHT) appeared first on The Wall Street Transcript.
|
|
Oct 19, 2018
Manuel Litchman, M.D., President, Chief Executive Officer and Director of Mustang Bio, Inc. Dr. Litchman has served as President and Chief Executive Officer and has been a member of Mustang's board of directors since April 2017. Dr. Litchman joined Mustang from Arvinas, LLC, where he served as President and Chief Executive Officer. While at Arvinas, […]
The post Litchman, Manuel appeared first on The Wall Street Transcript.
|
|
Oct 19, 2018
Geoff MacKay is President and Chief Executive Officer of AVROBIO, Inc. Mr. MacKay is an experienced CEO with proven success leading innovative businesses. While CEO of Organogenesis Inc., the company treated 1 million patients with living cell therapies, received the first FDA CBER allogeneic cell-therapy approval and achieved an unparalleled position within regenerative medicine. Mr. […]
The post MacKay, Geoff appeared first on The Wall Street Transcript.
|
|
Oct 19, 2018
Bernard Gilly, Ph.D., a Co-Founder of GenSight Biologics, has served as its Chief Executive Officer since its founding. From creation through to 2016, Dr. Gilly served as Chairman of the board of directors. From 2011 through 2014, he served as Chief Executive Officer at Pixium Vision, and from which date, he has served as nonexecutive […]
The post Gilly, Bernard appeared first on The Wall Street Transcript.
|
|
Oct 18, 2018
Joe Miller, CPA, is Chief Financial Officer of Cerecor Inc. Mr. Miller brings over 20 years of experience and a wealth of financial knowledge as a senior executive with extensive hands-on experience in managing financial operations and supporting enterprise growth across the health sciences, biotech and pharmaceutical sectors. In his previous role at Sucampo Pharmaceuticals, […]
The post Cerecor Turnaround Has Already Resulted in Positive EBITDA Projection by End of FY 2018 appeared first on The Wall Street Transcript.
|
|
Oct 18, 2018
Richard Chin, M.D., is Founder and Chief Executive Officer of Kindred Biosciences, Inc. Dr. Richard Chin is a Harvard-trained physician and a former Rhodes Scholar with a track record of almost a dozen drug approvals and over 50 INDs. Dr. Chin has developed several drugs for immune diseases, including Lucentis, Xolair, Tysabri and Rituxan. These […]
The post Kindred Biosciences Has Tremendous Risk Return Profile According to CEO Dr. Richard Chin appeared first on The Wall Street Transcript.
|
|
Oct 18, 2018
Robert Forrester, LL.B., is President and Chief Executive Officer of Verastem, Inc. Mr. Forrester has 18 years of experience as the CEO, COO or CFO of both private and public life science companies with Verastem Oncology; Forma Therapeutics; CombinatoRx (NASDAQ:CRXX), now ZLCS; and Coley (NASDAQ:COLY), which was acquired by Pfizer. Mr. Forrester was a managing […]
The post Novel PI3K Delta and Gamma Inhibitor from Verastem Creates Opportunity for Investors appeared first on The Wall Street Transcript.
|
|
Oct 18, 2018
Steven Seedhouse, Ph.D., is Biotech Research Analyst at Raymond James Financial, Inc. Dr. Seedhouse has been a biotech equity research analyst or associate since 2015 at various firms. In this exclusive 4,014 word interview in the Wall Street Transcript, Dr. Seedhouse handicaps the coming wave of NASH treatment Phase III trials. He joined Raymond James […]
The post Dr. Steven Seedhouse of Raymond James Assigns Probabilities to Near Term NASH Readouts Success appeared first on The Wall Street Transcript.
|
|
Oct 17, 2018
Terry Rosen, Ph.D., is the Chief Executive Officer of Arcus Biosciences. Dr. Rosen has been leading successful drug discovery and development organizations in the biotechnology and pharmaceutical industries for over 30 years. In 2015, he co-founded Arcus Biosciences, a drug discovery company focused on the treatment of cancer by blocking tumor-induced immunosuppression. Previously, he was […]
The post Breast Cancer Treatment Developed by Arcus Biosciences Ready for Expanded Testing appeared first on The Wall Street Transcript.
|
|
Oct 15, 2018
Walter V. Klemp is President, Chief Executive Officer and Chairman of Moleculin Biotech, Inc. Mr. Klemp has been Moleculin Biotech's Co-Founder, Chairman and CEO since 2007. Mr. Klemp has 29 years of experience in startup and high growth companies, the past nine of which have been spent developing FDA-approved dermatology therapy devices and topical compounds. Mr. […]
The post Moleculin Biotech CEO Walter Klemp Wants to Advance this Cure for Cancer appeared first on The Wall Street Transcript.
|
|
Oct 15, 2018
Lucy Lu, M.D., is President and Chief Executive Officer of Avenue Therapeutics, Inc. Dr. Lu has been the company's President and Chief Executive Officer since inception. From February 2012 to June 2017, Dr. Lu was the Executive Vice President and Chief Financial Officer of Fortress Biotech, Inc. Prior to working in the biotech industry, Dr. […]
The post Avenue Therapeutics (NASDAQ:ATXI) CEO and President Lucy Lu, M.D., has a Replacement for Medical Opiods appeared first on The Wall Street Transcript.
|
|
Oct 15, 2018
Ernest Loumaye, M.D., Ph.D., is Co-Founder and Chief Executive Officer of ObsEva SA, the in vitro fertilization drug development comany. Dr. Ernest Loumaye has brought extensive experience in pharma product development and the management of biopharmaceutical companies to ObsEva. After a brief academic career at Louvain University Hospital, he joined Serono as head of clinical […]
The post In Vitro Fertilization Method is a Belgian Medical Success Story: An Interview with Dr. Ernest Louaye, M.D., Ph.D. appeared first on The Wall Street Transcript.
|
|
Private Label